3 Cancer Treatment Stocks to Buy Right Now
Cancer treatment has come a long way over the last few decades, but we've still got a ways to go before we can officially say that we've eradicated the disease.
So, which cancer-focused companies are best positioned to deliver for their investors? We asked a team of our healthcare contributors to weigh in and they picked Bristol-Myers Squibb (NYSE: BMY), Exelixis (NASDAQ: EXEL), and Guardant Health (NASDAQ: GH).
Image source: Getty Images.
Quelle Fool.com
